Post-SCOTUS BRCA Litigation | GenomeWeb

This post has been updated to clarify which of Myriad's claims were upheld by the Supreme Court.

So, if the US Supreme Court has now said that human genes are not patentable under US law, then why are the new gene testing companies that have jumped into the BRCA testing game in the wake of the ruling getting sued, the Washington Post WonkBlog's Timothy Lee asks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.